Epigenomics
IPOBerlin, Germany · Founded 1998 · $22.5M raised
- Headquarters
- Berlin
- Founded
- 1998
- Business Model
- B2B
- Website
- epigenomics.com
- Total Funding
- $22.5M
- Last Round
- $22.5M Series CApr 2008
- Rounds
- 1
About
Epigenomics AG is a molecular diagnostics company developing blood-based DNA methylation tests for early cancer detection.
Summary
Epigenomics is a Biotech company based in Berlin, Germany, founded in 1998. It has raised $22.5M in total across 1 round, most recently a $22.5M Series C round in Apr 2008. Investors include Omega Funds.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2017
Sign up to see all 3 rounds
IPO through Secondary Market — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/epigenomics"><img src="https://indexed.vc/api/badge/company/epigenomics" alt="Epigenomics on Indexed.vc" width="260" height="76" /></a>